Insights of FIH and EFS use of DurAVR (Anteris Technologies) a single-leaflet design biomimetic valve are presented at #EuroPCR by Chris Meduri

#PCRLV : Azeem Latib presents insights from the first in man implant of the DurAVR biomimetic TAVI valve (@AnterisTech). He reports that the device had a favourable safety profile, and “outstanding” haemodynamic performance

⭐️ FIH & EFS data on DurAVR just presented by Azeem Latib #PCRLV

🎯Balloon-expandable
🎯Commissure-alignment
🎯Long coaptation length
🎯EXCELLENT Hemodynamics

Chris Meduri, MD MPH Anteris Technologies Montefiore Heart

Visionary work led by Pankaj Garg looking at the impact of aortic flow abnormalities on CV disease. Likely an important feature in future AVR development. João Cavalcante RTHahnMD Janar Sathananthan Stephanie Sellers

Great week at TCT with incredible data being presented by Anteris demonstrating superior MPG's ,superior EOA's and superior DVI's to current therapies. A huge thanks to our team,Physicians and patients. We are moving the conversation forward ! #proudtobeanteris #DurAVR

An insight into why aortic flow is becoming a novel therapeutic target.
In collaboration with world experts in aortic physiology. natureNews Nature Reviews Cardiology nature
#WhyCMR #4DFlowCMR
Thanks ALL (@chrismeduri) and legendary Michael Markl!
Paper ⬇️
nature.com/articles/s4156…

DurAVR US EFS results presented TCTMD by Azeem Latib today

In small annuli patients (mean 22.2):

✔️ safe, easy to use
✔️ no pacemakers
✔️ 93% no/trace, 7% mild PVL

🎯mean EOA 2.36
🎯MPG 7.8
🎯DVI 0.71

This groundbreaking, first biomimetic valve will change AS treatment

It is with great pleasure to announce the completion of the DurAVR EFS enrollment! Thank you U-M Health Frankel CVC. This first-in-class biomimetic valve exceeded already remarkable prior results. More details next week in San Fran TCTMD and in London as a LBCT PCRonline 🫀. Anteris Technologies #tavr

Congratulations to the incredible team Cleveland Clinic for 3 great DurAVR cases last week. All with excellent results! Always great seeing good friends Rishi Puri Amar Krishnaswamy Samir Kapadia and super fellow Travis Howard ! Look forward to more soon! #tavr PCRonline 🫀 TCTMD

Congratulations to Thomas Waggoner and his team on 2 outstanding DurAVR cases this week. Seeing your team do a pristine case in only 20 minutes is a testament to your whole program! Look forward to many more soon. Anteris Technologies

Incredibly work by Montefiore Heart and proud of Anteris Technologies to announce the first patients enrolled in the DurAVR US EFS study. The first US patients treated with a biomimetic valve! Incredible results, small annuli with mean EOA of 2.2 and mean gradient of 4 acutely! Azeem Latib

An incredible result for this patient from a remarkable team. Congrats Anita Asgar and team! More to come!
Janar Sathananthan João Cavalcante RTHahnMD thomas modine Dr. Nicolas M Van Mieghem Andreas Rück Dr. Gilbert Tang Thomas Waggoner Gorav Ailawadi Stephanie Sellers Azeem Latib vinayak bapat

Great article by Michael O'Riordan on the impact/importance of no-implant shunts. RF allows for a durable septectomy.

.Chris Meduri, MD MPH presents the latest data from the DurAVR™ THV FIH Study demonstrating sustained haemodynamic performance at 1 year. #TAVR $AVR #TAVI #cardiology #AnterisTech #TVT2023

#Anteristech announces powerful new data from the DurAVR™ THV FIH Study demonstrating sustained haemodynamic performance at 1 year in 12 patients. #TAVR $AVR #TAVI #cardiology #AnterisTech

Read Full Announcement: links.anteristech.com/3MVmdNf

New biomimetic #TAVR valve linked to strong performance after 1 year Anteris Technologies João Cavalcante Chris Meduri, MD MPH Pankaj Garg EuroIntervention Susheel Kodali, MD Columbia Valve Center Columbia Medicine #DurAVR #cardiology #cardiotwitter ow.ly/kNc150Ow1ol

Dr. Gilbert Tang Chris Meduri, MD MPH vinayak bapat Susheel Kodali, MD Paul PCRonline 🫀 EuroIntervention MIЯVΛƬ #IC Isaac George MD Didier Tchetche David J. Cohen, MD, MSc thomas modine EduardoSaadi Tsuyoshi Kaneko More details here: m.youtube.com/watch?v=20E4xv…

Is this the next breakthrough in tissue #TAVR ? Congrats Chris Meduri, MD MPH vinayak bapat Susheel Kodali, MD Paul on DurAVR 1y data PCRonline 🫀 #PCR2023 EuroIntervention look fwd to EFS! MIЯVΛƬ #IC Isaac George MD Didier Tchetche David J. Cohen, MD, MSc thomas modine EduardoSaadi Tsuyoshi Kaneko

The DurAVR transcatheter heart valve was evaluated in a first-in-human study for treating symptomatic severe aortic stenosis. The study demonstrated a good safety profile and promising haemodynamic performance sustained at 1 year. #EAPCI #EUROPCR ow.ly/Lvya50OsBmL